US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a deal valued at approximately Y510bn ($3.3bn). The ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

BLACKSTONE is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private ...

Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi "expansion phase" on the horizon. And more. 1. Astellas shifts investment focus to later ...

Japan's Seven & I, the parent company of the Japanese 7-Eleven convenience store chain, says it is selling its supermarket ...

TOKYO -- U.S. private equity firm Bain Capital on Monday withdrew its planned bid to take over Japan's Fuji Soft, ending a battle to acquire the systems developer that had been raging with rival ...